Search

Your search keyword '"Manoharan, Muthiah"' showing total 248 results

Search Constraints

Start Over You searched for: Author "Manoharan, Muthiah" Remove constraint Author: "Manoharan, Muthiah" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
248 results on '"Manoharan, Muthiah"'

Search Results

1. Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAs.

3. Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates

4. Conformation matters: siRNAs with antisense strands with 5'-(E)-vinyl-phosphonate-A-L-LNA elicit stronger RNAi-mediated gene silencing than those with 5'-(E)-vinyl-phosphonate-LNA.

5. Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates

10. Multivalent N‑Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

14. Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAs

21. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

22. Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways

25. Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy

27. Challenges and Opportunities for Nucleic Acid Therapeutics

28. Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes. Molecules 2022, 27, 3944

30. Role of a “Magic” Methyl: 2′-Deoxy-2′-α-F-2′-β-C-methyl Pyrimidine Nucleotides Modulate RNA Interference Activity through Synergy with 5′-Phosphate Mimics and Mitigation of Off-Target Effects

31. From bench to bedside: Improving the clinical safety of GalNAc–siRNA conjugates using seed-pairing destabilization

34. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes

35. Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes. Molecules 2022, 27, 3944

36. An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia

37. RNAs Containing Carbocyclic Ribonucleotides

39. Expanding the Reach of RNAi Therapeutics with Next Generation Lipophilic siRNA Conjugates

40. Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs

41. Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing

42. Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo

43. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of N-Acetylgalactosamine–Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to Human

44. Centyrin ligands for extrahepatic delivery of siRNA

45. Efficient Downregulation of Alk4in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy

46. siRNAs containing 2′-fluorinated Northern-methanocarbacyclic (2′-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2′-F-NMC NTPs

48. Synthesis, chirality-dependent conformational and biological properties of siRNAs containing 5′-(R)- and 5′-(S)-C-methyl-guanosine

49. Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates

Catalog

Books, media, physical & digital resources